Trial · NCT02528253
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo Followed by Tanezumab 5 mg | 205 | |
| Overall Study | STARTED | Placebo Followed by Tanezumab 10 mg | 204 | |
| Overall Study | STARTED | Pooled Tanezumab 5 mg | 407 | |
| Overall Study | STARTED | Pooled Tanezumab 10 mg | 407 | |
| Overall Study | STARTED | Tramadol | 602 | |
| Overall Study | Intent to Treat Population | Placebo Followed by Tanezumab 5 mg | 202 | |
| Overall Study | Intent to Treat Population | Placebo Followed by Tanezumab 10 mg | 204 | |
| Overall Study | Intent to Treat Population | Pooled Tanezumab 5 mg | 407 | |
| Overall Study | Intent to Treat Population | Pooled Tanezumab 10 mg | 407 | |
| Overall Study | Intent to Treat Population | Tramadol | 605 | |
| Overall Study | Treated at Week 16 | Placebo Followed by Tanezumab 5 mg | 99 | |
| Overall Study | Treated at Week 16 | Placebo Followed by Tanezumab 10 mg | 95 | |
| Overall Study | Treated at Week 16 | Pooled Tanezumab 5 mg | 236 | |
| Overall Study | Treated at Week 16 | Pooled Tanezumab 10 mg | 242 | |
| Overall Study | Treated at Week 16 | Tramadol | 307 | |
| Overall Study | COMPLETED | Placebo Followed by Tanezumab 5 mg | 130 | |
| Overall Study | COMPLETED | Placebo Followed by Tanezumab 10 mg | 134 | |
| Overall Study | COMPLETED | Pooled Tanezumab 5 mg | 267 | |
| Overall Study | COMPLETED | Pooled Tanezumab 10 mg | 271 | |
| Overall Study | COMPLETED | Tramadol | 379 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02528253/flow